Republic of the Philippines
Department of Health
OFFICE OF THE SECRETARY
San Lazaro Compound, Rizal Avenue, Manila

Telephone No: 743-83-01 to 23 loc. 1125-1126

<date>03/26/2001</date>

<doctype>ADMINISTRATIVE ORDER</doctype>
<docnum>No. 1-A, s. 2001</docnum>

<subject>
SUBJECT: USE OF HYDROQUINONE AND/0R TRETNOIN (RETINOIC ACID)</subject>

<body>
In accordance with the provisions of Republic Act 3720, otherwise known as Food, Drugs, Devices and Cosmetic Act, as amended, the following amendments to A.O. 13 s. 1999 are promulgated:

1. All preparations containing hydroquinone as the only active ingredient in concentrations not exceeding 2% are classiﬁed as cosmetics;

2. All preparations containing hydroquinone as the only active ingredients in concentrations exceeding 2% but not more than 4% are considered prescription drugs and as such are to be dispensed only in registered drug outlets by a licensed pharmacist

3. All preparations containing more than 4% hydroquinone are not allowed and are not registrable;

4. All preparations containing hydroquinone up to 4% and in combination with tretinoin or similar compounds are claSSIﬁed as prescription drugs as in (2);

5. All preparations containing tretinoin as the only active ingredient are classified as: 

i) Household remedy, if the concentration of tretinoin does not exceed
- 0.05% for creams
- 0.025% for gels and lotions 

ii) Prescription drug if the concentration of tretinoin exceeds
- 0.05% for creams
— 0.025% for gels and lotions

6. All preparations containing tretinoin in any amount but in combination with another active compound are classiﬁed as prescription drugs. 

Appropriate labeling as to its preper use and adequate warnings as to its possible side effects must be indicated for all products with hydroquinone, tretinoin or any combination thereof.

All other administrative issuances or parts thereof, inconsistent with the provisions of this order are hereby amended, repealed and modiﬁed accordingly.

This order shall take effect ﬁfteen (15) days after its publication in a newspaper of general circulation.


</body>
<sign>MANUEL M. DAYRIT, MD, MSc.</sign>
<signtitle>Secretary of Health</signtitle>